The management of transient monocular visual loss

Journal of Neuro-Ophthalmology

Volumn 25, Issue 4, 2005, Pages 304-312

  Caplan, Louis R ^a,b   Hertzer, Norman R ^c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANAMNESIS; CASE REPORT; CLINICAL FEATURE; HUMAN; HYPERTENSION; MALE; MONOCULAR VISION; NEUROLOGIC EXAMINATION; PHYSICAL EXAMINATION; PRIORITY JOURNAL; REVIEW; VISUAL IMPAIRMENT; ANGIOPLASTY; ARTICLE; BLINDNESS; CAROTID ARTERY OBSTRUCTION; CAROTID ENDARTERECTOMY; DOPPLER ECHOGRAPHY; ECHOGRAPHY; INTERNAL CAROTID ARTERY; MIDDLE AGED; RETINA ARTERY OCCLUSION; STENT;

ANGIOPLASTY; BLINDNESS; CAROTID ARTERY, INTERNAL; CAROTID STENOSIS; ENDARTERECTOMY, CAROTID; HUMANS; MALE; MIDDLE AGED; RETINAL ARTERY OCCLUSION; STENTS; ULTRASONOGRAPHY, DOPPLER, DUPLEX;

EID: 33644874881     PISSN: 10708022     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.wno.0000190062.33744.68     Document Type: Review

References (56)

1. Caplan LR. Transient ischemia and brain and ocular infarction. In: Albert DM, Jakobiec FA, eds. Principles and Practice of Ophthalmology. Vol 4. Philadelphia: WB Saunders; 1994:2653-69.
2. Wray SH. Visual symptoms (eye). In: Bogousslavsky J, Caplan LR, eds. Stroke Syndromes. 2nd ed. Cambridge, UK: Cambridge University Press; 2001:111-28.
3. Caplan LR. Transient visual loss. MedLink Neurology. San Diego: MedLink Corporation, c2001-2005. Available from: http://www.medlink.com. Accessed: September 15, 2005.
4. Shuler RK Jr, Biousse V, Newman NJ. Transient monocular visual loss in two patients with impending central retinal vein occlusion. J Neuroophthalmol 2005;25:152-4.
5. Purvin V, King R, Kawasaki A, et al. Anterior ischemic optic neuropathy in eyes with optic disc drusen. Arch Ophthalmol 2004;122:48-53.
6. Reichel E, Duker JS, Puliafito CA, et al. Branch retinal arterial occlusion caused by a preretinal arterial loop. Neurology 1994;44:1181-3.
7. Sloan MA, Alexandrov AV, Tegeler CH, et al. Assessment: transcranial Doppler ultrasonography: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 2004;62:1468-81.
8. Sitzer M, Siebler M, Steinmetz H. Silent emboli and their relation to clinical symptoms in extracranial carotid artery disease. Cerebrovasc Dis 1995;5:121-3.
9. Droste DW, Dittrich R, Kemeny V, et al. Prevalence and frequency of microembolic signals in 105 patients with extracranial carotid artery occlusive disease. J Neurol Neurosurg Psychiatry 1999;67:525-8.
10. Nicolaides AN, Papadakis K, Grigg M, et al. Data from CT scans: the significance of silent cerebral infarction and atrophy. In: Bernstein EF, ed. Amaurosis Fugax. New York: Springer-Verlag; 1988:200-26.
11. Caplan LR. Significance of unexpected (silent) brain infarcts in cerebrovascular ischaemia, investigation and management. In: Caplan LR, Shifrin EG, Nicolaides AN, et al., eds. Cerebrovascular Ischemia: Investigation and Management. London: Med Orion; 1996:423-33.
12. Caplan LR. Brain embolism. In: Caplan LR, Hurst JW, Chimowitz MI, eds. Clinical Neurocardiology. New York: Marcel Dekker; 1999:35-185.
13. Gupta R, Krieger DW. Preventing ischemic stroke: choosing the best strategy. Cleve Clin J Med 2005;72:433-44.
14. International Stroke Trial Collaborative Group. International stroke trial (IST): a randomized trial of aspirin, subcutaneous heparin, both, or neither among 19,435 patients with acute ischaemic stroke. Lancet 1997;349:1569-81.
15. Erdoes LS, Marck JM, Mills JL, et al. The relative contributions of carotid duplex scanning, magnetic resonance angiography, and cerebral arteriography to clinical decision-making: a prospective study in patients with carotid occlusive disease. J Vasc Surg 1996;23:950-6.
16. Streifler JY, Ekiasziw M, Benavente OR, et al. The risk of stroke in patients with first-ever retinal vs hemispheric transient ischemic attacks and high-grade carotid stenosis. Arch Neurol 1995;52:246-9.
17. Bucher HC, Griffith LE, Guyatt GH. Effect of HMGcoA reductase inhibitors on stroke: a meta-analysis of randomized, controlled trials. Ann Intern Med 1998;128:89-95.
18. Furberg CD, Adams HP Jr, Applegate WB, et al. Effect of lovostatin on early carotid atherosclerosis and cardiovascular events. Circulation 1994;90:1679-87.
19. Crouse JR 3rd, Byington RP, Bond MG, et al. Pravastatin, lipids, and atherosclerosis in the carotid arteries (PLAC II). Am J Cardiol 1995;75:455-9.
20. Hodis HN, Mack WJ, LaBree L, et al. Reduction in carotid arterial wall thickness using lovastatin and dietary therapy: a randomized controlled clinical trial. Ann Intern Med 1996;124:548-56.
21. Chapman N, Huxley R, Anderson C, et al. Effects of a perindopril-based blood pressure-lowering regimen on the risk of recurrent stroke according to stroke subtype and medical history: the PROGRESS Trial. Stroke 2004;35:116-21.
22. Bosch J, Yusuf S, Pogue J, et al. Use of Ramipril in preventing stroke: double blind randomized trial. BMJ 2002;324:699-702.
23. Gronholdt ML, Nordestgaard BG, Nielsen TG, et al. Echolucent carotid artery plaques are associated with elevated levels of fasting and postprandial triglyceride-rich lipoproteins. Stroke 1996;27:2166-72.
24. European Carotid Plaque Study Group. Carotid artery plaque composition: relationship to clinical presentation and ultrasound B-mode imaging. Eur J Vasc Endovasc Surg 1995;10:23-30.
25. Geroulakos G, Ramaswami G, Nicolaides A, et al. Characterization of symptomatic and asymptomatic carotid plaques using high-resolution real-time ultrasonography. Br J Surg 1993;80:1274-127.
26. Siebler M, Kleinschmidt A, Sitzer M, et al. Cerebral microembolism in symptomatic and asymptomatic high-grade internal carotid artery stenosis. Neurology 1994;44:615-8.
27. Ries S, Schminke U, Daffertshofer M, et al. High-intensity transcranial signals in carotid artery disease. Cerebrovasc Dis 1995;5:124-7.
28. Siebler M, Sitzer M, Rose G, et al. Silent cerebral embolism caused by neurologically symptomatic high-grade carotid stenosis: event rates before and after CE. Brain 1993;116:1005-1.
29. North American Symptomatic Carotid Endarterectomy Trial Collaborators. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med 1991;325:445-53.
30. Barnett HJ, Taylor DW, Eliasziw M, et al. Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. N Engl J Med 1998;339:1415-25.
31. Benavente O, Eliasziw M, Steifler JY, et al. Prognosis after transient monocular blindness associated with carotid artery stenosis. N Engl J Med 2001;345:1084-90.
32. Executive Committee for the Asymptomatic Carotid Atherosclerosis Study. Endarterectomy for asymptomatic carotid artery stenosis. JAMA 1995;273:1421-8.
33. LaMuraglia GM, Brewster DC, Moncure AC, et al. Carotid endarterectomy at the millennium: what interventional therapy must match. Ann Surg 2004;240:535-46.
34. Mohammed N, Anand SS MRC. Asymptomatic Carotid Surgery Trial (ACST) Collaborative Group. Prevention of disabling and fatal strokes by successful carotid endarterectomy in patients without recent neurological symptoms: randomised controlled trial. Lancet 2004;363:1491-502.
35. Yadav JS, Wholey MH, Kuntz RE, et al. Protected carotid-artery stenting versus endarterectomy in high-risk patients. N Engl J Med 2004;351:1493-501.
36. Wholey MH, Al-Mubarek N, Wholey MH. Updated review of the global carotid artery stent registry. Catheter Cardiovasc Interv 2003;60:259-66.
37. Kastrup A, Groschel K, Krapf H, et al. Early outcome of carotid angioplasty and stenting with and without cerebral protection devices: a systematic review of the literature. Stroke 2003;34:813-9.
38. Meyers PM, Schumacher C, Higashida RT, et al. Use of stents in the treatment of cerebrovascular disease. Ann Rev Med (in press).
39. Diethrich EB, Ndiaye M, Reid DB. Stenting in the carotid artery: Initial experience in 110 patients. J Endovasc Surg 1996;3:42-6.
40. Golledge J, Mitchell A, Greenhalgh RM, et al. Systematic comparison of the early outcome of angioplasty and endarterectomy for symptomatic carotid artery disease. Stroke 2000;31:1439-43.
41. CAVATAS Investigators. Endovascular versus surgical treatment in patients with carotid stenosis in the Carotid and Vertebral Artery Transluminal Angioplasty Study (CAVATAS): a randomised trial. Lancet 2001;357:1729-37.
42. CARESS Steering Committee. Carotid revascularization using endarterectomy or stenting systems (CARESS): phase I clinical trial. J Endovasc Ther 2003;10:1021-30.
43. Hobson RW II, Brott TG, Roubin GS, et al. Carotid artery stenting: meeting the recruitment challenge of a clinical trial. Stroke 2005;36:1314-5.
44. Hobson RWII, Howard VJ, Roubin GS, et al. Carotid artery stenting is associated with increased complications in octogenarians: 30-day stroke and death rates in the CREST lead-in phase. J Vasc Surg 2004;40:1106-11.
45. Kastrup A, Schulz JB, Raygrotzki S, et al. Comparison of angioplasty and stenting with cerebral protection versus endarterectomy for treatment of internal carotid artery stenosis in elderly patients. J Vasc Surg 2004;40:945-51.
46. Bull DA, Fante RG, Hunter GC, et al. Correlation of ophthalmic findings with carotid artery stenosis. J Cardiovasc Surg 1992;33:401-6.
47. Wakefield MC, O'Donnell SD, Goff JM Jr. Re-evaluation of carotid duplex for visual complaints: who really needs to be studied? Ann Vasc Surg 2003;17:635-40.
48. McCullough HK, Reinert CG, Hynan LS, et al. Ocular findings as predictors of carotid artery occlusive disease: is carotid imaging justified? J Vasc Surg 2004;40:279-86.
49. Recchia FM, Brown GC. Systemic disorders associated with retinal vascular occlusion. Curr Opin Ophthalmol 2000;11:462-7.
50. Schwarcz TH, Eton D, Ellenby MI, et al. Hollenhorst plaques: retinal manifestations and the role of carotid endarterectomy. J Vasc Surg 1990;11:635-41.
51. Bunt TJ. The clinical significance of the asymptomatic Hollenhorst plaque. J Vasc Surg 1986;4:559-62.
52. Bond R, Rerkasem K, Naylor AR, et al. Systematic review of randomized controlled trials of patch angioplasty versus primary closure and different types of patch materials during carotid endarterectomy. J Vasc Surg 2004;40:1126-35.
53. AbuRahma AF, Robinson PA, Mullins DA, et al. Frequency of postoperative carotid duplex surveillance and type of closure: results from a randomized trial. J Vasc Surg 2000;32:1043-51.
54. Moore WS, Kempczinski RF, Nelson JJ, et al. Recurrent carotid stenosis: results of the asymptomatic carotid atherosclerosis study. Stroke 1998;29:2018-25.
55. Hertzer NR, O'Hara PJ, Mascha EJ, et al. Early outcome assessment for 2228 consecutive carotid endarterectomy procedures: The Cleveland Clinic Experience from 1989 to 1995. J Vasc Surg 1997;26:1-10.
56. Archie JP Jr. A fifteen-year experience with carotid endarterectomy after a formal operative protocol requiring highly frequent patch angioplasty. J Vasc Surg 2000;31:724-35.